Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
Murthy
S Narasimha
SN
Molecular and Cellular Biophysics Department, Roswell Park Cancer Institute, Elm and Carlton St., Buffalo, NY 14263, USA. snarasimha.murthy@roswellpark.org
Zhao
Ya-Li
YL
Sen
Arindam
A
Hui
Sek Wen
SW
D000073738:2-Hydroxypropyl-beta-cyclodextrin; D000279:Administration, Cutaneous; D000818:Animals; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D004058:Diffusion / Q000187:drug effects; D004337:Drug Carriers / Q000737:chemistry / Q000493:pharmacokinetics; D018274:Electroporation / Q000379:methods* / Q000639:trends; D005452:Fluoresceins / Q000737:chemistry / Q000493:pharmacokinetics*; D010894:Piroxicam / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D012867:Skin / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology; D013501:Surface-Active Agents / Q000737:chemistry / Q000493:pharmacokinetics; D013552:Swine; D047392:beta-Cyclodextrins / Q000737:chemistry / Q000493:pharmacokinetics*
D004337:Drug Carriers; D005452:Fluoresceins; D013501:Surface-Active Agents; D047392:beta-Cyclodextrins; D010894:Piroxicam; D000073738:2-Hydroxypropyl-beta-cyclodextrin; C024098:6-carboxyfluorescein